CD1: Difference between revisions
CSV import |
CSV import |
||
| Line 29: | Line 29: | ||
{{stub}} | {{stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 05:59, 17 March 2025
CD1 (cluster of differentiation 1) is a family of glycoproteins expressed on the surface of various human antigen-presenting cells. They are related to the class I MHC molecules, and are involved in the presentation of lipid antigens to T cells. However their precise function is unknown.
Structure[edit]
CD1 molecules are structurally similar to the major histocompatibility complex (MHC) class I molecules, however, the CD1 lipid antigen presentation pathway is distinct from the classical MHC peptide antigen presentation pathway. CD1 molecules are transmembrane proteins that have a heavy chain and a light chain. The heavy chain contains three domains: alpha1, alpha2, and alpha3. The alpha1 and alpha2 domains form the antigen-binding groove, which is composed of six pockets (A' to F').
Function[edit]
CD1 proteins are involved in the presentation of lipid antigens to T cells. Lipid antigens can be presented by CD1 molecules to T cells, which can then initiate an immune response. The precise function of CD1 molecules is still unknown, but they are thought to play a role in the immune response to infections and in autoimmune diseases.
Types[edit]
There are five types of human CD1 molecules: CD1a, CD1b, CD1c, CD1d, and CD1e. CD1a, CD1b, and CD1c present foreign lipid antigens, while CD1d presents self lipid antigens. CD1e is involved in lipid antigen processing.
Clinical significance[edit]
CD1 molecules have been implicated in a variety of diseases, including tuberculosis, leprosy, and autoimmune diseases. They are also being investigated for their potential use in cancer immunotherapy.
See also[edit]
- Cluster of differentiation
- Antigen-presenting cell
- Major histocompatibility complex
- T cell
- Autoimmune disease
- Cancer immunotherapy
References[edit]
<references />
|
|
|

